DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea · Delayed Price · Currency is KRW 3,300.00
-50.00 (-1.49%)
At close: Oct 23, 2026
DongKoo Bio & Pharma Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 241,434 | 242,688 | 249,275 | 215,686 | 194,988 | 155,149 |
Revenue Growth | -0.46% | -2.64% | 15.57% | 10.62% | 25.68% | 11.45% |
Gross Profit Gross Profit Growth | 139,730 | 144,342 | 151,887 | 132,076 | 117,860 | 92,337 |
Operating Income Operating Income Growth | 339.04 | 9,248 | 12,691 | 14,616 | 16,836 | 8,139 |
Net Income Net Income Growth | 33,013 | 50,272 | 2,036 | 11,812 | 6,614 | 9,327 |
Earnings Per Share EPS Growth | 1190.89 | 1790.73 | 74.54 | 427.63 | 238.29 | 330.05 |
EPS Growth | 445.59% | 2302.50% | -82.57% | 79.46% | -27.80% | 2.16% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
New Technology Business Financing New Technology Business Financing Growth | 10,729 | 12,339 | 2,141 | 966.08 | 709.83 |
Connection Adjustment Connection Adjustment Growth | -1,431 | -2,100 | -3,744 | -2,517 | -1,275 |
Pharmaceutical manufacturing industry Pharmaceutical manufacturing industry Growth | 232,136 | 230,844 | 247,528 | 214,877 | 194,434 |
Pharmaceutical marketing agency Pharmaceutical marketing agency Growth | - | 1,604 | 3,351 | 2,360 | 1,119 |
Total Total Growth | 241,434 | 242,688 | 249,275 | 215,686 | 194,988 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 51,011 | 35,165 | 36,250 | 22,898 | 35,136 | 32,100 |
Total Debt Total Debt Growth | 122,630 | 128,782 | 86,641 | 43,804 | 34,322 | 24,294 |
Net Cash (Debt) Net Cash Growth | -71,619 | -93,617 | -50,391 | -20,906 | 813.88 | 7,806 |
Net Cash Growth | - | - | - | - | -89.57% | 33.61% |
Net Cash Per Share Net Cash Per Share Growth | -2580.25 | -3329.90 | -1845.19 | -756.89 | 29.32 | 276.23 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 21,195 | -4,287 | 17,344 | 3,585 | 16,819 | 17,903 |
Capital Expenditures CapEx Growth | -21,703 | -17,656 | -21,866 | -13,845 | -4,978 | -4,266 |
Free Cash Flow Free Cash Flow Growth | -507.99 | -21,944 | -4,522 | -10,260 | 11,841 | 13,637 |
Free Cash Flow Growth | - | - | - | - | -13.16% | 514.06% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.88% | 59.48% | 60.93% | 61.23% | 60.45% | 59.51% |
Operating Margin | 0.14% | 3.81% | 5.09% | 6.78% | 8.63% | 5.25% |
Pretax Margin | 17.78% | 25.31% | 1.53% | 6.83% | 4.06% | 7.30% |
Profit Margin | 13.67% | 20.71% | 0.82% | 5.48% | 3.39% | 6.01% |
FCF Margin | -0.21% | -9.04% | -1.81% | -4.76% | 6.07% | 8.79% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 120.000 | 120.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 3.64% | 2.19% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2.77 | 2.94 | 64.38 | 13.24 | 25.64 | 24.94 |
P/FCF Ratio | - | - | - | - | 14.32 | 17.05 |
PS Ratio | 0.37 | 0.61 | 0.53 | 0.73 | 0.87 | 1.50 |